USPTO serial 79346601
Serial No. 79346601
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 7, 2023
- Examiner
- FRENCH, CURTIS W
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79346601?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
M. Scott Alprin
M. Scott Alprin Alprin Law Offices, P.C.5 Pinehurst Circle, N.W.Washington, DC 20015UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Industrial chemicals; glue and adhesives for industrial purposes; plant growth regulating preparations; fertilizers; ceramic glazing in the nature of a dry chemical preparation for use in the manufacture of ceramics; Glaziers' priming putty; oil cement putty; higher fatty acids for industrial purposes; alkaline metals; alkaline-earth metals; non- metallic industrial minerals; chemical compositions for developing and printing photographs; reagent paper not for medical purposes; artificial sweeteners; flour and starch for industrial purposes; Unprocessed plastic in the form of powder or granules; groundwood pulp and chemiground wood pulps for manufacturing purposes; nucleic acid reagents not for medical purposes; chemical reagent for non-medical purposes for diagnosing molecular sequence of biological material such as nucleic acid; chemical reagents for non-medical purposes for use in isolation of ribonucleic acid in physical and chemical experiments; buffer solution and chemical reagent used to introduce molecules such as nucleic acids or their molecular assemblies into cells such as prokaryotic and eukaryotic cells, for non-medical purposes; nucleic acid sequences, other than for medical or veterinary purposes; nucleic acids for scientific purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; chemical reagent for analyzing nucleic acid in kit, except for medical or veterinary use; chemical reagent for analyzing nucleic acid, except for medical or veterinary use; reagent for detecting or quantifying nucleic acid, except for medical or veterinary use; chemical diagnostic reagents for production and analysis of nucleic acid, for scientific and industrial use; nucleolytic enzyme for scientific and research purposes; reagent for detecting nucleic acid mutation, except for medical or veterinary use; Industrial chemicals for nucleic acid analysis in kit form comprised of detection reagents; Industrial chemicals used as raw materials for conjugation with nucleic acid substances for introducing nucleic acid substances into cells; nucleic acid for use in the manufacture of pharmaceuticals; diagnostic reagents and preparations, except for medical or veterinary use; chemical reagents for use in genetic research for non-medical purposes; reagents for use in genetic research, except for medical or veterinary use; reagents for chemical and research purposes for non-medical purposes | ACTIVE | — |
| 005 | Pharmaceutical preparations for use in treating liver diseases, renal disease, central nerve system diseases, namely, degenerative nerve system diseases, cerebral infarction, central hemorrhage, and spinal cord injury, autonomic nervous system diseases, sensory organs diseases, neuromuscular diseases, skin diseases, cardiovascular diseases, vascular and venous diseases, infectious diseases, cancer, allergic diseases, respiratory diseases, diseases affecting digestive organs, diseases affecting uro-genitial and anal organs, chemically caused disorders, namely, chemical burn and side effect of anticancer drugs, inflammation of brain, eye, ear, nose, mouth, throat, heart, lung, liver, gall bladder, pancreas, spleen, stomach, intestines, testis, prostate, ovary, uterus, kidney, urinary bladder, skin, muscle, bone, neuron, pain derived from injury, diseases, inflammation, side effect of drugs and toxic reagent; Vermin destroying preparations, fungicides, and herbicides; reagent paper for medical purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; Capsules sold empty for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; materials for medical dressings; liquid bandages for skin wounds; breast-nursing pads; cotton swabs for medical use; Materials for dental fillings; Incontinence diapers; Infant diaper covers; fly catching paper; mothproofing paper; lacteal flour for babies; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; Nutritionally fortified beverages for babies for medical purposes; food for babies; dietary supplements for animals; semen for artificial insemination; nucleic acid medicine for use in treating liver diseases, renal disease, central nerve system diseases, namely, degenerative nerve system diseases, cerebral infarction, central hemorrhage, and spinal cord injury, autonomic nervous system diseases, sensory organs diseases, neuromuscular diseases, skin diseases, cardiovascular diseases, vascular and venous diseases, infectious diseases, cancer, allergic diseases, respiratory diseases, diseases affecting digestive organs, diseases affecting uro-genitial and anal organs, chemically caused disorders, namely, chemical burn and side effect of anticancer drugs, inflammation of brain, eye, ear, nose, mouth, throat, heart, lung, liver, gall bladder, pancreas, spleen, stomach, intestines, testis, prostate, ovary, uterus, kidney, urinary bladder, skin, muscle, bone, neuron, pain derived from injury, diseases, inflammation, side effect of drugs and toxic reagent; reagents for detection, identification, analysis, and quantification of nucleic acid for medicine and medical diagnosis; diagnostic reagents for use in isolation of ribonucleic acid in clinical trials relating to medical services; reagent for detection of nucleic acid mutations for medical purposes; reagents for nucleic acid extraction for medical purposes; reagents for medical purposes for nucleic acid extraction in kit form comprised of detection reagents; reagents for medical, clinical, clinical examination and diagnosis relating to amplification, analysis and labeling of nucleic acid, and diagnostic reagents used as kits comprised of detection reagents; nucleic acid sequences for medical and veterinary purposes; nutritional supplements consisting primarily of nucleic acid in granular, liquid, tablet, powder, soft capsule, or capsule form; pharmaceutical preparations and reagents for in vitro diagnostic; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing | ACTIVE | — |
| 040 | Rental of chemical processing machines and apparatus; providing information relating to material treatment; cryopreservation services; custom manufacturing of nucleic acid materials or synthesis of nucleic acids; custom manufacture of chemical substances; custom manufacture of pharmaceuticals; custom manufacture of synthetic nucleic acids; custom manufacture or preparation of pharmaceuticals; custom extraction, purification, or manufacturing of pharmaceuticals, agricultural preparations, and veterinary preparations; providing information relating to custom preparation and processing of chemicals; custom preparation and processing of chemicals; custom production and processing of proteins and chemicals | ACTIVE | — |
| 042 | Providing meteorological information; meteorological information; architectural design; architectural services; surveying; geological surveys and research; geological research; designing for others of machines, apparatus, instruments and their parts, and systems composed of such machines, apparatus and instruments; Engineering design services; computer software design, computer programming, or maintenance of computer software; computer programming; technological advice relating to computers, automobiles and industrial machines; testing, inspection and research of pharmaceuticals, cosmetics or foodstuffs; research on building construction and city planning; testing or research on prevention of pollution; testing or research on electricity; testing or research on civil engineering; testing, inspection or research on agriculture, livestock breeding or fisheries; product testing and research on machines, apparatus and instruments; rental of measuring apparatus; rental of computers; installing computer programs on data networks; rental of laboratory apparatus and instruments; rental of technical drawing instruments; Pharmaceutical product development; providing advice, consultancy, and information relating to development of pharmaceuticals; testing, inspection, and research relating to pharmaceuticals, and providing advice, consultancy, and information relating thereto; providing information about medical and scientific research in the field of pharmaceuticals; pharmaceutical product evaluation; research and development services relating to medicines; testing of pharmaceuticals; research on the subject of pharmaceuticals; consultancy relating to pharmaceutical research and development; conducting clinical trials for other relating to pharmaceuticals; providing product information about the results of clinical trials for pharmaceuticals; testing of chemicals; development and test of chemical production methods; design of chemical manufacturing plants; advice relating to testing, inspection, or research of chemicals; providing information about testing, inspection, or research of chemicals; testing, inspection, evaluation, or research of chemicals; testing, inspection, or research relating to chemicals; research and development of chemicals; custom pharmaceutical development; custom development of pharmaceuticals | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Luxna Biotech Co., Ltd.
- Other trademarks owned by Luxna Biotech Co., Ltd.
- Other trademarks owned by Luxna Biotech Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 14, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 4, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 9, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 8, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 7, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 7, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 7, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 22, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 22, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 21, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 2, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 2, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 2, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 14, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 10, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 9, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 9, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 2, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 10, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 10, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 27, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 26, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 24, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 9, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 5, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 4, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |